To charge or not to charge: Mechanistic insights into neuropathy-associated tRNA synthetase mutations

Current Opinion in Genetics and Development

Volumn 23, Issue 3, 2013, Pages 302-309

  Wallen, Rachel C ^a   Antonellis, Anthony ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE; AMINO ACID TRANSFER RNA LIGASE; AMINOACYLTRANSFERASE; ARGININE; ASPARAGINE; GLUTAMINE; GLYCINE; GLYCINE TRANSFER RNA LIGASE; HISTIDINE; LYSINE; METHIONINE; PHENYLALANINE; PYROPHOSPHATE; SERINE; TRANSFER RNA; TYROSINE;

CONTROLLED STUDY; CYTOPLASM; ENZYME BINDING; GENE LOCUS; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LOSS OF FUNCTION MUTATION; MITOCHONDRION; NEUROPATHY; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SPINAL MUSCULAR ATROPHY;

AMINO ACYL-TRNA SYNTHETASES; CHARCOT-MARIE-TOOTH DISEASE; HUMANS; MUTATION; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; PROTEIN BIOSYNTHESIS;

EID: 84879883281     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.02.002     Document Type: Review

References (44)

1. Delarue M. Aminoacyl-tRNA synthetases. Curr Opin Struct Biol 1995, 5:48-55.
2. Antonellis A., Green E.D. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008, 9:87-107.
3. Riley L.G., Cooper S., Hickey P., Rudinger-Thirion J., McKenzie M., Compton A., Lim S.C., Thorburn D., Ryan M.T., Giegé R., et al. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia-MLASA syndrome. Am J Hum Genet 2010, 87:52-59.
4. Götz A., Tyynismaa H., Euro L., Ellonen P., Hyötyläinen T., Ojala T., Hämäläinen R.H., Tommiska J., Raivio T., Oresic M., et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 2011, 88:635-642.
5. Martyn C.N., Hughes R.A. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997, 62:310-318.
6. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974, 6:98-118.
7. Dyck P.J., Lambert E.H. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968, 18:619-625.
8. Antonellis A., Ellsworth R.E., Sambuughin N., Puls I., Abel A., Lee-Lin S.-Q., Jordanova A., Kremensky I., Christodoulou K., Middleton L.T., et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003, 72:1293-1299.
9. Del Bo R., Locatelli F., Corti S., Scarlato M., Ghezzi S., Prelle A., Fagiolari G., Moggio M., Carpo M., Bresolin N., et al. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology 2006, 66:752-754.
10. James P.A., Cader M.Z., Muntoni F., Childs A.-M., Crow Y.J., Talbot K. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology 2006, 67:1710-1712.
11. Rohkamm B., Reilly M.M., Lochmüller H., Schlotter-Weigel B., Barisic N., Schöls L., Nicholson G., Pareyson D., Laurà M., Janecke A.R., et al. Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci 2007, 263:100-106.
12. Eskuri J.M., Stanley C.M., Moore S.A., Mathews K.D. Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS. J Peripher Nerv Syst 2012, 17:132-134.
13. Abe A., Hayasaka K. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy. J Hum Genet 2009, 54:310-312.
14. Sivakumar K., Kyriakides T., Puls I., Nicholson G.A., Funalot B., Antonellis A., Sambuughin N., Christodoulou K., Beggs J.L., Zamba-Papanicolaou E., et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 2005, 128:2304-2314.
15. Jordanova A., Irobi J., Thomas F.P., Van Dijck P., Meerschaert K., Dewil M., Dierick I., Jacobs A., De Vriendt E., Guergueltcheva V., et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006, 38:197-202.
16. Latour P., Thauvin-Robinet C., Baudelet-Méry C., Soichot P., Cusin V., Faivre L., Locatelli M.-C., Mayençon M., Sarcey A., Broussolle E., et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 2010, 86:77-82.
17. Lin K.-P, Soong B.-W., Yang C.-C., Huang L.-W., Chang M.-H., Lee I.-H., Antonellis A., Antonellis A., Lee Y.-C. The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan. PLoS ONE 2011, 6:e29393.
18. McLaughlin H.M., Sakaguchi R., Giblin W., Intramural Sequencing Center N.I.H., Wilson T.E., Biesecker L., Lupski J.R., Talbot K., Vance J.M., Züchner S., et al. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Hum Mutat 2012, 33:244-253.
19. Zhao Z., Hashiguchi A., Hu J., Sakiyama Y., Okamoto Y., Tokunaga S., Zhu L., Shen H., Takashima H. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology 2012, 78:1644-1649.
20. McLaughlin H.M., Sakaguchi R., Liu C., Igarashi T., Pehlivan D., Chu K., Iyer R., Cruz P., Cherukuri P.F., Hansen N.F., et al. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 2010, 87:560-566.
21. Vester A., Velez-Ruiz G., McLaughlin H.M., NISC Comparative Sequencing Program, Lupski J.R., Talbot K., Vance J.M., Züchner S., Roda R.H., Fischbeck K.H., et al. A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat 2013, 34:191-199.
22. Jung H., Yoon B.C., Holt C.E. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat Rev Neurosci 2012, 13:308-324.
23. Scheper G.C., van der Knaap M.S., Proud C.G. Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet 2007, 8:711-723.
24. Antonellis A., Lee-Lin S.-Q., Wasterlain A., Leo P., Quezado M., Goldfarb L.G., Myung K., Burgess S., Fischbeck K.H., Green E.D. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J Neurosci 2006, 26:10397-10406.
25. Nangle L.A., Zhang W., Xie W., Yang X.-L., Schimmel P. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci U S A 2007, 104:11239-11244.
26. Chihara T., Luginbuhl D., Luo L. Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization. Nat Neurosci 2007, 10:828-837.
27. Seburn K.L., Nangle L.A., Cox G.A., Schimmel P., Burgess R.W. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 2006, 51:715-726.
28. Strachan T., Read A.P. Human Molecular Genetics 1999, Wiley-Liss.
29. Inoue K., Khajavi M., Ohyama T., Hirabayashi S.-I., Wilson J., Reggin J.D., Mancias P., Butler I.J., Wilkinson M.F., Wegner M., et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 2004, 36:361-369.
30. Motley W.W., Seburn K.L., Nawaz M.H., Miers K.E., Cheng J., Antonellis A., Green E.D., Talbot K., Yang X.-L., Fischbeck K.H., et al. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet 2011, 7:e1002399.
31. Park S.G., Ewalt K.L., Kim S. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 2005, 30:569-574.
32. Dong J., Qiu H., Garcia-Barrio M., Anderson J., Hinnebusch A.G. Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain. Mol Cell 2000, 6:269-279.
33. Lee J.W., Beebe K., Nangle L.A., Jang J., Longo-Guess C.M., Cook S.A., Davisson M.T., Sundberg J.P., Schimmel P., Ackerman S.L. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443:50-55.
34. Stum M., McLaughlin H.M., Kleinbrink E.L., Miers K.E., Ackerman S.L., Seburn K.L., Antonellis A., Burgess R.W. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci 2011, 46:432-443.
35. Scheper G.C., van der Klok T., van Andel R.J., van Berkel C.G.M., Sissler M., Smet J., Muravina T.I., Serkov S.V., Uziel G., Bugiani M., et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007, 39:534-539.
36. Steenweg M.E., Ghezzi D., Haack T., Abbink T.E.M., Martinelli D., van Berkel C.G.M., Bley A., Diogo L., Grillo E., Water Naudé Te J., et al. Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. Brain 2012, 135:1387-1394.
37. Elo J.M., Yadavalli S.S., Euro L., Isohanni P., Götz A., Carroll C.J., Valanne L., Alkuraya F.S., Uusimaa J., Paetau A., et al. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet 2012, 21:4521-4529.
38. Pierce S.B., Chisholm K.M., Lynch E.D., Lee M.K., Walsh T., Opitz J.M., Li W., Klevit R.E., King M.-C. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A 2011, 108:6543-6548.
39. Bayat V., Thiffault I., Jaiswal M., Tétreault M., Donti T., Sasarman F., Bernard G., Demers-Lamarche J., Dicaire M.-J., Mathieu J., et al. Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS Biol 2012, 10:e1001288.
40. Edvardson S., Shaag A., Kolesnikova O., Gomori J.M., Tarassov I., Einbinder T., Saada A., Elpeleg O. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 2007, 81:857-862.
41. Belostotsky R., Ben-Shalom E., Rinat C., Becker-Cohen R., Feinstein S., Zeligson S., Segel R., Elpeleg O., Nassar S., Frishberg Y. Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet 2011, 88:193-200.
42. Xie W., Nangle L.A., Zhang W., Schimmel P., Yang X.-L. Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc Natl Acad Sci U S A 2007, 104:9976-9981.
43. Cader M.Z., Ren J., James P.A., Bird L.E., Talbot K., Stammers D.K. Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy. FEBS Lett 2007, 581:2959-2964.
44. Froelich C.A., First E.A. Dominant intermediate Charcot-Marie-Tooth disorder is not due to a catalytic defect in tyrosyl-tRNA synthetase. Biochemistry 2011, 50:7132-7145.